Literature DB >> 27753752

Percutaneous Lung Biopsy in the Molecular Profiling Era: A Survey of Current Practices.

Christopher Lee1, Phillip L Guichet, Fereidoun Abtin.   

Abstract

PURPOSE: This study aimed to assess the current practice patterns of radiologists performing percutaneous lung biopsies.
MATERIALS AND METHODS: This cross-sectional study used a web-based survey sent to the Society of Thoracic Radiology membership from August to October 2015. Responses were collected anonymously, and results were tallied.
RESULTS: A total of 244 Society of Thoracic Radiology members responded to the survey. One hundred thirty-seven radiologists regularly perform percutaneous lung biopsies, of whom 102 (74%) practice at an academic teaching hospital. Computed tomography (CT) and CT fluoroscopy were the modalities of choice for image guidance, preferred by 82 (60%) and 48 (35%) respondents, respectively. Twenty (15%) respondents preferred fine-needle aspiration (FNA) alone, 57 (42%) preferred core needle biopsy (CNB) alone, and 59 (43%) preferred both FNA and CNB in the same setting. On-site cytology was routinely requested by 70 (71%) respondents with access to such services. In cases of suspected lung cancer, 79 (60%) respondents estimated sending tissue for molecular analysis >25% of the time. Forty-three (32%) respondents reported using intraprocedural preventive measures to minimize risk of pneumothorax.
CONCLUSIONS: Among surveyed radiologists who perform percutaneous lung biopsies, most utilize CT guidance with either CNB alone or in conjunction with FNA. A small minority routinely performs FNA alone, which may negatively impact diagnostic accuracy and provide insufficient tissue for molecular profiling. Education of all radiologists regarding the importance of routinely acquiring and sending greater amounts of tissue for molecular/genomic assessment of suspected lung cancer is needed.

Entities:  

Mesh:

Year:  2017        PMID: 27753752     DOI: 10.1097/RTI.0000000000000237

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  10 in total

Review 1.  Ground glass opacities management in the lung cancer screening era.

Authors:  Marcello Migliore; Mariaconcetta Fornito; Manuela Palazzolo; Alessandra Criscione; Mariapia Gangemi; Francesco Borrata; Paolo Vigneri; Marco Nardini; Joel Dunning
Journal:  Ann Transl Med       Date:  2018-03

2.  CT-guided coaxial biopsy of malignant lung lesions: are cores from 20-gauge needle adequate for histologic diagnosis and molecular analysis?

Authors:  Kyongmin S Beck; Tae-Jung Kim; Kyo Young Lee; Young Kyoon Kim; Jin Hyoung Kang; Dae Hee Han
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

3.  Practice Pattern of Transthoracic Needle Biopsy: 2016 Survey in the Members of Korean Society of Thoracic Radiology.

Authors:  Yeseul Jo; Dae Hee Han; Kyongmin Sarah Beck; Jai Soung Park; Tae Jung Kim
Journal:  Korean J Radiol       Date:  2017-09-21       Impact factor: 3.500

4.  Diagnostic Performance of Core Needle Biopsy and Fine Needle Aspiration Separately or Together in the Diagnosis of Intrathoracic Lesions Under C-arm Guidance.

Authors:  Youkyung Lee; Choong-Ki Park; Young-Ha Oh
Journal:  J Belg Soc Radiol       Date:  2018-12-12       Impact factor: 1.894

Review 5.  2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology.

Authors:  Soon Ho Yoon; Sang Min Lee; Chul Hwan Park; Jong Hyuk Lee; Hyungjin Kim; Kum Ju Chae; Kwang Nam Jin; Kyung Hee Lee; Jung Im Kim; Jung Hee Hong; Eui Jin Hwang; Heekyung Kim; Young Joo Suh; Samina Park; Young Sik Park; Dong Wan Kim; Miyoung Choi; Chang Min Park
Journal:  Korean J Radiol       Date:  2020-11-19       Impact factor: 3.500

6.  Value of low-dose and optimized-length computed tomography (CT) scan in CT-guided percutaneous transthoracic needle biopsy of pulmonary nodules.

Authors:  Hui Yuan; Da Li; Yan Zhang; Xiaozhen Xie; Lujun Shen
Journal:  J Interv Med       Date:  2021-05-21

7.  Supplementary benefits of CT-guided transthoracic lung aspiration biopsy for core needle biopsy.

Authors:  Jia-Huan He; Jia-Xing Ruan; Ying Lei; Zhi-Dan Hua; Xiang Chen; Da Huang; Cheng-Shui Chen; Xu-Ru Jin
Journal:  Front Microbiol       Date:  2022-09-14       Impact factor: 6.064

8.  Utility of liquid-based cytology on residual needle rinses collected from core needle biopsy for lung nodule diagnosis.

Authors:  Zhihua Lan; Xiaoli Zhang; Xin Ma; Yiyan Hu; Jing Zhang; Fang Yang
Journal:  Cancer Med       Date:  2021-05-07       Impact factor: 4.452

9.  Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.

Authors:  Wei-Ran Liu; Bin Zhang; Chen Chen; Yue Li; Xin Ye; Dong-Jiang Tang; Jun-Cheng Zhang; Jing Ma; Yan-Ling Zhou; Xian-Jun Fan; Dong-Sheng Yue; Chen-Guang Li; Hua Zhang; Yu-Chen Ma; Yan-Song Huo; Zhen-Fa Zhang; Shu-Yu He; Chang-Li Wang
Journal:  Thorac Cancer       Date:  2020-09-28       Impact factor: 3.500

10.  Tissue Adequacy and Safety of Percutaneous Transthoracic Needle Biopsy for Molecular Analysis in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Authors:  Bo Da Nam; Soon Ho Yoon; Hyunsook Hong; Jung Hwa Hwang; Jin Mo Goo; Suyeon Park
Journal:  Korean J Radiol       Date:  2021-08-31       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.